Directorate Change

RNS Number : 0498Q

Indivior PLC

16 October 2019

 

Indivior PLC - Directorate Change

Slough UK and Richmond VA October 16, 2019 - The Board of Indivior PLC is pleased to announce the appointment of Graham Hetherington as an independent Non-Executive Director of the Company with effect from November 1, 2019.  Graham will also be appointed as a member of the Audit Committee with effect from the same date.

Howard Pien, Chair, commented:

'As announced in July 2019, we have undertaken an external search to identify an additional independent Non-Executive Director.  We are delighted to announce that Graham Hetherington has agreed to join the Board.  Graham brings with him a strong track record of industry and financial experience having served as the Chief Financial Officer of two FTSE 100 companies.  Until recently, Graham was Senior Independent Director and Chair of the Audit Committee of BTG plc, a global healthcare company.'

Graham was Chair of the Audit Committee of BTG plc from 2016 and Senior Independent Director from 2017 until its acquisition by Boston Scientific Corporation in August 2019.  He was previously Chief Financial Officer of Shire PLC, a global pharmaceutical company with a market capitalisation of over £33bn, from 2008 until 2014, Chief Financial Officer of Bacardi and Company between 2007-08 and Chief Financial Officer of Allied Domecq plc from 1999 to 2005.  He is a Fellow of the Chartered Institute of Management Accountants.

There is no further information to disclose in relation to Graham Hetherington's appointment in accordance with LR 9.6.13.

 

END

 

 

BOAMFBRTMBABMTL